✦ LIBER ✦

Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors

✍ Scribed by Michael Piepkorn

Book ID: 117844486
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 260 KB
Volume: 42
Category: Article
ISSN: 1097-6787
DOI: 10.1067/mjd.2000.104687

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alterations of the Tumor Suppressor Gene

Alterations of the Tumor Suppressor Genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in Atypical and Anaplastic Meningiomas

✍ Jan Boström; Birgit Meyer-Puttlitz; Marietta Wolter; Britta Blaschke; Ruthild G. 📂 Article 📅 2001 🏛 American Society for Investigative Pathology 🌐 English ⚖ 476 KB

Frequency of mutation and deletion of th

Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population

✍ K Biden; J Young; R Buttenshaw; J Searle; G Cooksley; D B Xu; B Leggett 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

The tumor suppressor gene CDKN2A (MTS1/p16), located on chromosome 9p21, is inactivated in a variety of tumors including melanomas and tumors of the biliary tract, pancreas, and stomach. The aim of the present study was to determine whether this gene is inactivated in hepatocellular carcinoma (HCC).